About MELD Health™

David Hanna is a life sciences and technology executive with deep experience leading at the intersection of science and business to drive transformational growth for innovative companies active in the clinical sector. His unique blend of technical, commercial, and scientific expertise is a cornerstone of his ability to bring novel precision medicine solutions through engagements in pharma and large medical institutions. He has led cross-functional teams across North America, Europe, the Middle East, Africa, Asia, and Oceania, consistently delivering results in complex, matrix organizational environments.

A natural mentor and coach, he has been recognized for developing high-performing technical sales teams, nurturing talent, and building global business development capacity across cultures and geographies and has demonstrated a commitment to inspiring and motivating top talent.

He spent 15 years in commercial leadership roles at the pioneering genomics company Affymetrix until its acquisition by Thermo Fisher Scientific in 2016. Prior to that, he had commercial roles at Incyte Corporation, PerkinElmer, and Agilent Technologies where he was consistently recognized for exceptional sales performance and strategic thinking.  Most recently as CCO he led commercialization efforts for Intelliseq, an EU-based bioinformatics company.

He earned his Ph.D. in biochemistry from the University of Georgia and was a postdoctoral fellow at both Johns Hopkins University and Centers for Disease Control and Prevention.

Dr. Alexandre DaSilva is internationally recognized for his groundbreaking work at the intersection of migraine/pain neuroscience and digital health. As an Endowed Professor at the University of Michigan and Director of the H.O.P.E. (Headache & Orofacial Pain Effort) Laboratory, Dr. DaSilva leads a multidisciplinary team focused on neuroscience-driven innovations for chronic pain disorders like migraine, temporomandibular disorders (TMD), and fibromyalgia.

With advanced training in oral biology and clinical pain management from Harvard University, followed by research in migraine/pain neuroimaging at Massachusetts General Hospital and McLean Hospital, Dr. DaSilva has pioneered novel approaches using neuroimaging, non-invasive brain stimulation, and advanced health technologies—including generative AI, mobile platforms, and AR/VR.

His research has contributed to new ways clinicians and scientists understand, diagnose, and treat chronic migraine/pain—earning support from multiple branches of the NIH and widespread recognition in both scientific circles and mainstream media, including the Discovery Channel, US Today, and Scientific American Mind.

At MELD Health, Dr. DaSilva brings his expertise to reimagine how patients and providers connect and communicate about pain. He guides the development and integration of our MELD Health’s products, ensuring that every innovation is rooted in robust science and driven by compassion for those suffering from chronic pain and migraine.

“Our central R&D objective at MELD Health is to finally unlock true understanding between patients and clinicians—making every experience visible, measurable, and actionable, so pain care, relief and healing are no longer out of reach.” Dr. DaSilva

Javid is a technical leader with 20+ years of experience building enterprise AI for healthcare and life sciences. He leads all technology, product and AI efforts at MELD Health. As the Founder and CTO of BioMedict, he pioneered the first AI-driven remote pain management platform using multi-modal embeddings and LLMs.

Previously, Javid led Health AI Product Management at Google Research, directing foundational model research for chronic disease prediction. His career is marked by high-scale technical leadership, including serving as VP of Product & Engineering at Monster, where he led worldwide search and AI-matching technologies, and as a global leader at McKinsey & Company, advising on digital transformation and technical strategy.

A lead inventor on multiple NLP and AI patents, Javid bridges the gap between deep technical innovation and US healthcare regulatory compliance (HIPAA). His collaborative research at Harvard Medical School and MIT SUD Bootcamp awarded by NIDA, focuses on risk-stratification for pain, sleep, and mental health. He holds an MBA from Boston College and a B.E. in Electronics and Communications.

Cristian Minoccheri is an AI/ML engineer building AI for healthcare. With a PhD in Mathematics, he has developed machine learning methods for medical applications at the University of Michigan Medical School and School of Dentistry. His work spans interpretable AI, tensor methods, large language models (LLM), and generative models, applied to clinical phenotyping, medical imaging, signal processing, and patient prognosis. He has collaborated closely with clinicians across specialties and worked with a wide range of biomedical data, including time series, X-ray and CT images, electronic medical records, molecular data, and clinical notes.   Christian leads and drives all LLM-related activities and strategies for MELD Health.

Jim is a veteran executive of six startups in multiple industries, including medical diagnostics and software organizations. His experience spans fund raising support, customer focused business and operating plan development, startup formation, company growth management, and regulatory navigation.

In his most recent endeavor, as co-founder and Chief Operating Officer of Armune BioScience, Inc., Jim participated in corporate startup and strategy decisions and established a CLIA R&D and commercial facility that supported the development, sale, and processing of prostate cancer diagnostic tests. Armune was acquired by Exact Sciences Corp. (Nasdaq: EXAS) in 2017. Previously, as president of Biomedical Diagnostics, Jim formed and organized the company and implemented full R&D operations and CLIA commercial services to support a breast cancer risk assessment assay.

Jim was operations executive at grapeVINE Technologies, a startup knowledge management software company that was acquired by Netscape/SUN Microsystems in 1999. He enjoyed a 19-year senior management and executive career at Comshare, an Ann Arbor based software company that sold financial and personnel management software and services to Fortune 500 customers. He is also the founder and president of Quality Results Management Services, a business management consulting firm that offers interim CEO and other advisory services, and helps clients, especially startups, focus on customers and quality management methods. Jim holds a BSEE from The Pennsylvania State University.